This Dutchman Is Flying
This Dutchman Is Flying
Maverick biotech firm Genzyme is winning big profits from a contrarian strategy: Think small
GM crops 'good for developing countries'
GM crops ‘good for developing countries’ In a discussion paper out on Tuesday to coincide with a national GM debate in the UK, the influential Nuffield Council on Bio-ethics says the technology has the potential to increase crop yields and improve the livelihoods of poor people.
BIOTECH RALLIES
BIOTECH RALLIES The promise of new cancer therapies coming out of last week’s American Society of Clinical Oncology meeting in Chicago has helped restore vigor to the biopharmaceutical industry. It has also gotten a boost from a spate of new product approvals and generally upbeat earnings reports this year.
Financial Snapshot For May 2003: Yee Hah
Financial Snapshot For May 2003: Yee Hah The biotech sector has turned in a remarkable performance this year – especially in May, when the stocks took off like a rocket. And, so far, they’re still climbing…
BIOTECH TEMPERATURE RISES
BIOTECH TEMPERATURE RISES
Investors are showing classic symptoms of biotech fever.
They’re seizing on good news about drug trials, cheering new drug-related news and buying shares contagiously…
Get updates by email
Editor
Yali Friedman lives in Washington, DC and is author of Building Biotechnology and other books; founder of DrugPatentWatch; and chief editor of the Journal of Commercial Biotechnology.
and Share
Reading
Translator
© Copyright - BiotechBlog — A thinkBiotech product
Recent Comments